Stay updated on Open-Label Surufatinib in EU NET Patients Clinical Trial
Sign up to get notified when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.

Latest updates to the Open-Label Surufatinib in EU NET Patients Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedPage revision updated from v3.6.2 to v3.6.3, indicating a new version of the document. The update records the revision change in the page metadata.SummaryDifference0.0%

- Check17 days agoChange DetectedA new revision tag 'Revision: v3.6.2' appears on the page, indicating an update to the page version/history rather than a change to study details.SummaryDifference0.0%

- Check31 days agoChange DetectedThe page now indicates that the study is no longer enrolling participants. New sections How to Read a Study Record, Common Questions, and How to Join a Study were added, the Intervention/Treatment label was updated, and the revision is now v3.6.0.SummaryDifference0.5%

- Check38 days agoChange DetectedRevision: v3.5.5 appears on the page, replacing the previous v3.5.4. This indicates a small platform update that does not change the study details or results presented.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page now shows a new revision number (v3.5.4) in place of the previous v3.5.3, indicating a backend update; the study details and layout remain unchanged.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page’s footer/version indicator was updated from revision v3.5.2 to v3.5.3.SummaryDifference0.0%

Stay in the know with updates to Open-Label Surufatinib in EU NET Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.